CFLOX POWER INJ

Rapid, Concentration-Dependent Bactericidal Action Against Broad-Spectrum Pathogens:
Ciprofloxacin's fluoroquinolone mechanism targets essential bacterial replication enzymes at the molecular level, delivering fast, irreversible bactericidal activity against both Gram-negative and Gram-positive organisms simultaneously. This broad-spectrum coverage makes Cflox Power a cutting-edge clinical choice in acute infections where the causative pathogen has not yet been identified providing confident empirical cover while culture and sensitivity results are pending, and ensuring no critical treatment time is lost in life-threatening clinical scenarios.

Injectable Format for Guaranteed Systemic Bioavailability:
Unlike oral ciprofloxacin formulations, which are subject to unpredictable gastrointestinal absorption particularly in dogs where oral bioavailability is variable and in cats where it may be significantly lower the injectable route delivers Ciprofloxacin directly into systemic circulation. This ensures consistent, therapeutically adequate plasma concentrations are reliably achieved across all target tissues, from the pulmonary parenchyma to the uterine endometrium, making Cflox Power the preferred choice in hospitalised, critically ill, or food-refusing animals.

Targeted Reproductive Health Recovery:
Cflox Power is a clinically validated treatment for bacterial reproductive tract conditions including metritis, pyometra, and infection-driven repeat breeding syndrome in cattle and buffalo conditions that are economically and reproductively devastating in dairy farming and livestock management. By eradicating the causative organisms at the uterine level, Ciprofloxacin supports endometrial recovery, restores normal reproductive function, and improves fertility outcomes, reducing culling rates and economic losses in breeding herds.

Multi-Dose 50 ml Vial for Clinical and Farm Efficiency:
The 50 ml multi-dose vial format, preserved with Benzyl Alcohol, allows multiple therapeutic doses to be drawn from a single vial under aseptic conditions, making Cflox Power a practically and economically efficient antibiotic solution for both veterinary clinic use and large-scale livestock treatment programmes. This format minimises waste and reduces per-dose cost in herd-level treatment scenarios where multiple animals require simultaneous antibiotic therapy.

Trusted Manufacture Under Multi-Regulatory Certified Conditions:
Produced by Intas Animal Health under the Neovet Division, Cflox Power benefits from Intas Pharmaceuticals' state-of-the-art manufacturing infrastructure approved by the US-FDA, UK-MHRA, TGA (Australia), WHO-GMP, EU-GMP, and multiple other international regulatory bodies ensuring that every vial meets the highest pharmaceutical quality, sterility, and potency standards available in veterinary injectable manufacturing.

How to Use:

Cflox Power Injection must be administered exclusively by a qualified veterinarian or under direct veterinary supervision. It must not be self-administered. The standard recommended dose is 15 ml per 300 kg body weight, administered by intramuscular (IM) or intravenous (IV) injection, once daily for three to five days or as directed by the attending veterinarian. For companion animals, the veterinarian will determine the appropriate dose based on species, body weight, the severity and site of infection, and the organism's suspected susceptibility profile. For IV administration, the injection must be delivered as a slow infusion over a minimum of 60 minutes rapid IV bolus injection is not appropriate and increases the risk of adverse reactions. Use strict aseptic technique for all vial access and injection procedures. Shake the vial gently before drawing each dose. Complete the full prescribed course of treatment even if clinical improvement is visible before completion premature discontinuation can lead to relapse and contributes to antimicrobial resistance development. Do not administer concomitantly with antacids, sucralfate, iron or calcium-containing products, theophylline, cyclosporine, or other quinolone antibiotics without explicit veterinary guidance, as clinically significant drug interactions may occur.

Storage Advice:

Store unopened Cflox Power Injection vials in a cool, dry place below 25°C, protected from direct sunlight and sources of heat. Do not freeze. Once the vial has been broached, store under refrigeration between 2°C and 8°C and use within the in-use period recommended on the label. Maintain strict aseptic technique during every withdrawal from the multi-dose vial. Discard any remaining contents at the end of the stated in-use period or if the solution shows any discolouration, particulate matter, or signs of contamination. Keep out of reach of children. Do not use after the best-before date printed on the vial label and outer carton.

About the Brand:

Intas Pharmaceuticals Limited was founded in 1976 and is headquartered in Ahmedabad, Gujarat, India today standing as one of India's leading vertically integrated global pharmaceutical companies with a turnover exceeding USD 2.5 billion and a presence spanning 85+ countries worldwide. Its Animal Health division, operating under the Neovet brand for companion animal and ruminant care, is ranked among the Top 3 animal health companies in India and holds leadership status in the Ruminant and Companion Animal Healthcare segments. Manufacturing across 17 ultra-modern facilities approved by the US-FDA, UK-MHRA, EU-GMP, TGA Australia, WHO-GMP, and multiple other international regulatory authorities, Intas Animal Health combines pharmaceutical-grade manufacturing rigour with a deep understanding of veterinary clinical needs developing innovative, reliable, and accessible solutions for anti-infective therapy, NSAID pain management, deworming, reproductive health, and nutritional care across large and small animals. The Neovet division's commitment to prime quality products, innovative solutions, and enhanced clinical convenience aligns with Animeal's commitment to providing only the most trusted, clinically validated prescription pharmaceuticals for your animal's care. Discover Intas Animal Health today.

Disclaimer:

Please note that while Cflox Power Injection is formulated from Ciprofloxacin IP 100 mg/ml a clinically established broad-spectrum fluoroquinolone antibiotic and is appropriate for use across multiple veterinary species including cattle, buffalo, dogs, cats, pigs, sheep, and goats, it is a prescription-only injectable pharmaceutical and must not be purchased, stored, or administered without a valid prescription from a licensed veterinarian. This product is not a substitute for veterinary diagnosis, and its use should ideally be guided by culture and sensitivity testing to ensure appropriate antimicrobial selection and to minimise the risk of contributing to antimicrobial resistance. Cflox Power Injection must not be used in puppies and kittens or in young growing animals where cartilage development may be at risk from fluoroquinolone exposure, unless the clinical severity of infection outweighs this risk as determined by the attending veterinarian. It should be used with caution in pregnant and lactating animals. For animals with pre-existing kidney disease, liver disease, or a history of seizure disorders, consult your veterinarian before use. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.